Table 1.
Characteristic | All (N=102,131) N (%) | NHL cases (N=712) N (%) |
---|---|---|
Sex | ||
Male | 86,479 (84·7) | 640 (89·9) |
Female | 15,652 (15·3) | 72 (10·1) |
Race/ethnicity | ||
Black | 41,123 (40·3) | 236 (33·2) |
White | 44,437 (43·5) | 385 (54·1) |
Hispanic | 6,888 (6·7) | 41 (5·8) |
Other | 4,070 (4·0) | 26 (3·7) |
Unknown imputed | 5,613 (5·5) | 24 (3·4) |
Age, years | ||
18–29 | 13,069 (12·8) | 54 (7·6) |
30–39 | 30,711 (30·1) | 199 (28·0) |
40–49 | 35,682 (34·9) | 283 (39·8) |
≥50 | 22,669 (22·2) | 176 (24·7) |
Calendar period | ||
1996–1999 | 32,230 (31·6) | 400 (56·2) |
2000–2003 | 25,794 (25·3) | 174 (24·4) |
2004–2007 | 19,710 (19·3) | 90 (12·6) |
2008–2011 | 18,194 (17·8) | 44 (6·2) |
2012–2014 | 6,203 (6·1) | 4 (0·6) |
Combination ART naive | ||
No | 33,792 (33·1) | 180 (25·3) |
Yes | 68,339 (66·9) | 532 (74·7) |
CD4 count, cells per μL | ||
<50 | 11,111 (10·9) | 106 (14·9) |
50–<100 | 6,773 (6·6) | 80 (11·2) |
100–<200 | 13,446 (13·2) | 143 (20·1) |
200–<350 | 22,109 (21·6) | 152 (21·3) |
350–<500 | 19,996 (19·6) | 115 (16·2) |
≥500 | 28,696 (28·1) | 116 (16·3) |
HIV RNA level, copies per mL | ||
≤500 | 30,869 (30·2) | 117 (16·4) |
>500–<10,000 | 20,653 (20·2) | 128 (18·0) |
10,000–<100,000 | 30,194 (29·6) | 259 (36·4) |
≥100,000 | 20,415 (20·0) | 208 (29·2) |
HIV risk group | ||
Injection drug use | 12,630 (12·4) | 87 (12·2) |
Men who have sex with men | 32,461 (31·8) | 206 (28·9) |
Heterosexual | 16,023 (15·7) | 74 (10·4) |
Other | 2,058 (2·0) | 16 (2·3) |
Unknown imputeda | 5,582 (5·5) | 35 (4·9) |
Unknown not imputeda | 33,374 (32·7) | 294 (41·3) |
Smoking status | ||
Ever | 54,670 (53·5) | 435 (61·1) |
Never | 19,355 (19·0) | 121 (17·0) |
Unknown imputeda | 15,610 (15·3) | 60 (8·4) |
Unknown not imputeda | 12,496 (12·2) | 96 (13·5) |
ART=antiretroviral therapy. NHL=non-Hodgkin lymphoma.
We imputed HIV risk group and smoking status for persons with unknown values, except for cohorts with a high proportion of unknowns, or, for smoking, with all the knowns being smokers.